Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1B |
| 2 |
Netflix
NFLX
|
+$721M |
| 3 |
Apple
AAPL
|
+$468M |
| 4 |
UnitedHealth
UNH
|
+$422M |
| 5 |
GE Vernova
GEV
|
+$376M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$673M |
| 2 |
Robinhood
HOOD
|
+$481M |
| 3 |
Meta Platforms (Facebook)
META
|
+$433M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$402M |
| 5 |
Palantir
PLTR
|
+$380M |
Sector Composition
| 1 | Technology | 19.67% |
| 2 | Healthcare | 15.34% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.51% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Gain Therapeutics
GANX
$62.9M
| $169K | ﹤0.01% |
+94,000
| New | +$169K |
|
3202
Urban One Class D
UONEK
$39.9M
| $166K | ﹤0.01% |
260,205
+13,100
| +5% | +$8.35K |
|
|
TAOX
3203
Tao Synergies Inc. Common Stock
TAOX
$21.9M
| $165K | ﹤0.01% |
+21,000
| New | +$165K |
|
3204
Rallybio
RLYB
$24.8M
| $164K | ﹤0.01% |
485,032
+88,532
| +22% | +$29.9K |
|
3205
Toro Corp
TORO
$51.5M
| $164K | ﹤0.01% |
75,000
+7,500
| +11% | +$16.4K |
|
3206
The Beauty Health Co
SKIN
$296M
| $163K | ﹤0.01% |
85,591
+20,300
| +31% | +$38.8K |
|
3207
Ebang International Holdings
EBON
$24.7M
| $162K | ﹤0.01% |
49,213
-500
| -1% | -$1.65K |
|
|
LND
3208
BrasilAgro
LND
$389M
| $162K | ﹤0.01% |
42,400
+4,400
| +12% | +$16.9K |
|
3209
American Shared Hospital Services
AMS
$16.3M
| $161K | ﹤0.01% |
66,700
-3,200
| -5% | -$7.71K |
|
|
LFT
3210
Lument Finance Trust
LFT
$122M
| $158K | ﹤0.01% |
71,283
-148,817
| -68% | -$329K |
|
3211
Co-Diagnostics
CODX
$12M
| $157K | ﹤0.01% |
561,022
+10,700
| +2% | +$3K |
|
3212
Glimpse Group
VRAR
$29.1M
| $157K | ﹤0.01% |
115,458
+25,666
| +29% | +$34.9K |
|
3213
Vasta Platform
VSTA
$366M
| $156K | ﹤0.01% |
36,600
+15,500
| +73% | +$66.2K |
|
3214
NanoViricides
NNVC
$23.1M
| $156K | ﹤0.01% |
111,400
+5,600
| +5% | +$7.84K |
|
|
ORKA
3215
Oruka Therapeutics, Inc. Common Stock
ORKA
$592M
| $156K | ﹤0.01% |
13,900
-21,900
| -61% | -$245K |
|
3216
GrowGeneration
GRWG
$92M
| $155K | ﹤0.01% |
166,110
-94,076
| -36% | -$88K |
|
3217
CPS Technologies
CPSH
$48.2M
| $155K | ﹤0.01% |
55,958
+1,000
| +2% | +$2.77K |
|
3218
Cohen & Co
COHN
$24.4M
| $155K | ﹤0.01% |
15,600
-2,731
| -15% | -$27.1K |
|
3219
Harte-Hanks
HHS
$26M
| $154K | ﹤0.01% |
38,800
-10,484
| -21% | -$41.7K |
|
|
IMAB
3220
I-MAB
IMAB
$349M
| $154K | ﹤0.01% |
63,700
-100
| -0.2% | -$242 |
|
|
CMCM
3221
Cheetah Mobile
CMCM
$224M
| $154K | ﹤0.01% |
32,845
-200
| -0.6% | -$936 |
|
3222
SIFCO Industries
SIF
$43.8M
| $153K | ﹤0.01% |
40,934
-5,762
| -12% | -$21.5K |
|
3223
Broadway Financial
BYFC
$70M
| $153K | ﹤0.01% |
21,049
+200
| +1% | +$1.45K |
|
3224
Ventyx Biosciences
VTYX
$170M
| $153K | ﹤0.01% |
71,300
-945,089
| -93% | -$2.02M |
|
3225
Arts-Way Manufacturing Co
ARTW
$16.1M
| $152K | ﹤0.01% |
66,274
+6,400
| +11% | +$14.7K |
|